Keyhole cardiac surgery saves $2000 per patient
This article was originally published in Clinica
New trial data on Heartport's port-access minimally invasive cardiac surgery system show that it saves an average of $2000 per patient, despite the cost of the technology, by shortening hospital stays and reducing the risks of surgical complications. The trial answers questions raised in previous studies by matching patients in the port-access group with those undergoing traditional open-chest surgery, says a leading surgeon at the New York University Medical Center where the trial was carried out.
You may also be interested in...
Biogen value-based contract with UPMC Health Plan ties payments to patient-reported outcomes for Tecfidera and Avonex. The company may seek something similar for Vumerity.
As interest in immune/inflammatory disease increases and savings achieved dip, payer focus on patient-reported outcomes for contracts reflects shift in focus, Avalere survey suggests.
After an eleventh-hour win last year that saw Congress repeal the medical device excise tax, AdvaMed is going more global. CEO Scott Whitaker sat down with Medtech Insight for a lengthy chat about what the lobby group will focus on in 2020, including reimbursement challenges, the upcoming medical device user-fee negotiations, and negotiations with governments that are key to the industry ecosystem.